Clinical Trial Update: Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing TAK-875 to glimepiride, both added to metformin, in type 2 diabetes; the study was terminated but efficacy and safety results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)
• TAK-875 (fasiglifam)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED | Results posted: 2016-06-01